<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xmlns="http://www.w3.org/1999/xhtml"><head><title>R: Women's Interagency HIV Study (WIHS)</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link rel="stylesheet" type="text/css" href="R.css" />
</head><body><div class="container">

<table width="100%" summary="page for wihs"><tr><td>wihs</td><td style="text-align: right;">R Documentation</td></tr></table>

<h2>Women's Interagency HIV Study (WIHS)</h2>

<h3>Description</h3>

<p>Competing risk data set involving AIDS in women.
</p>


<h3>Format</h3>

<p>A data frame containing:
</p>

<table summary="Rd table">
<tr>
 <td style="text-align: left;">
    time </td><td style="text-align: left;"> time to event</td>
</tr>
<tr>
 <td style="text-align: left;">
    status </td><td style="text-align: left;"> censoring status: 0=censoring, 1=HAART initiation, 2=AIDS/Death before HAART</td>
</tr>
<tr>
 <td style="text-align: left;">
    ageatfda </td><td style="text-align: left;"> age in years at time of FDA approval of first protease inhibitor</td>
</tr>
<tr>
 <td style="text-align: left;">
    idu </td><td style="text-align: left;"> history of IDU: 0=no history, 1=history</td>
</tr>
<tr>
 <td style="text-align: left;">
    black </td><td style="text-align: left;"> race:  0=not African-American; 1=African-American</td>
</tr>
<tr>
 <td style="text-align: left;">
    cd4nadir </td><td style="text-align: left;"> CD4 count (per 100 cells/ul)
  </td>
</tr>

</table>



<h3>Source</h3>

<p>Study included 1164 women enrolled in WIHS, who were alive, infected
with HIV, and free of clinical AIDS on December, 1995, when the first
protease inhibitor (saquinavir mesylate) was approved by the Federal
Drug Administration. Women were followed until the first of the
following occurred: treatment initiation, AIDS diagnosis, death, or
administrative censoring (September, 2006). Variables included history
of injection drug use at WIHS enrollment, whether an individual was
African American, age, and CD4 nadir prior to baseline.</p>


<h3>References</h3>

<p>Bacon M.C, von Wyl V., Alden C., et al. (2005). The Women's Interagency
HIV Study: an observational cohort brings clinical sciences to the
bench, <em>Clin Diagn Lab Immunol</em>, 12(9):1013-1019.
</p>


<h3>Examples</h3>

<pre>

data(wihs, package = "randomForestSRC")
wihs.obj &lt;- rfsrc(Surv(time, status) ~ ., wihs, nsplit = 3, ntree = 100)

</pre>


</div></body></html>
